Ouling Biology (688319.SH) intends to reduce its shareholding by no more than 3%

Wisdom Financial News APP, Olin Biotechnology (688319.SH) announced that, due to its own funding needs, controlling shareholder Shanghai Wushan plans to reduce its holdings of IPO company shares by up to 12.178 million shares through centralized bidding or block trades, with the number of shares to be divested not exceeding 3% of the company's current total share capital.